| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/22/2004 | EP0914119B1 Process for forming solid oral dosage forms of valsartan |
| 09/22/2004 | EP0841900B1 Pharmaceutical composition for detecting lung disease |
| 09/22/2004 | CN2642449Y Laser boring device for a full-automatic double-chamber osmotic pump controlled release tablet |
| 09/22/2004 | CN2642448Y Laser boring device for a double-chamber osmotic pump controlled release tablet |
| 09/22/2004 | CN1531526A Diaminedithiol derivatives and radiorhenium or radoitechnetium complex thereof; liver cancer-treating composition comprising radiorhenium complex and lipiodol; and kit for preparation of liver cancer |
| 09/22/2004 | CN1531439A Liposome targeting of matrix metalloproteinase inhibitors |
| 09/22/2004 | CN1531437A Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by body |
| 09/22/2004 | CN1531436A Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption |
| 09/22/2004 | CN1531430A Local used composition containing antifungal agent |
| 09/22/2004 | CN1531428A Novel pharmaceutical composition for administering N-0923 |
| 09/22/2004 | CN1531427A Premixed amiodarone parenteral solution and method for making the same |
| 09/22/2004 | CN1531424A SN-38 lipid complexes and methods of use |
| 09/22/2004 | CN1531423A Preparation of low dosage medicinal composition with uniform distribution and effect |
| 09/22/2004 | CN1531421A Liquid pharaceutical for oral delivery |
| 09/22/2004 | CN1531420A Pharmaceutical formulation for efficient administration of apomorphine, 6aR-(-)-N-propyl-norepomorphine and their derivatives and pro-drugs thereof |
| 09/22/2004 | CN1531419A In-situ gel formation of pectins |
| 09/22/2004 | CN1531418A Manufacturing dissolvable dosage forms |
| 09/22/2004 | CN1530139A Copmosition containnig dichloride sugar |
| 09/22/2004 | CN1530138A Stabilized medicine preparation form with by porous kietyoite covering flavour |
| 09/22/2004 | CN1530132A Tianfang xifeng huagu pillets |
| 09/22/2004 | CN1530129A Health care Husheng capsules for human blood health |
| 09/22/2004 | CN1530121A Preparation of manyprickle acanthopanax capsules |
| 09/22/2004 | CN1530120A Preparing method for compound Rhododendron dauricum dropping pellet |
| 09/22/2004 | CN1530114A Sustained releasing breviscapine tablets |
| 09/22/2004 | CN1530113A Breviscapine disperisng tablets composition and its preparation |
| 09/22/2004 | CN1530110A Naloxone freeze-drying powder injection and preparing technology thereof |
| 09/22/2004 | CN1530106A Medicine composition for treating diabet mellitus |
| 09/22/2004 | CN1530105A Medicine composition for treating diabets and mellitus |
| 09/22/2004 | CN1530104A Sustained releasing talbets for radioactive and chemical therpay and preparation thereof |
| 09/22/2004 | CN1530098A Local preparation for remitting pains and inflammation caused by nerpes virus |
| 09/22/2004 | CN1530096A Powder injection containing nonsteroidal anti-infecting chemical |
| 09/22/2004 | CN1167684C Non-ball shaped and non-flake type mercapto pyridine oxide salts and prepn. method therefor |
| 09/22/2004 | CN1167470C Controlled release tablet produced from linear water insoluble polysaccharides |
| 09/22/2004 | CN1167466C Oral medicinal preparation |
| 09/22/2004 | CN1167461C Carbon dioxide enhancement of inhalation therapy |
| 09/22/2004 | CN1167456C Compound paste of donkey-skin gelatin for enriching blood |
| 09/22/2004 | CN1167441C Xiangshen capsule and preparation and use thereof |
| 09/22/2004 | CN1167431C Chinese medicine plaster for treating mastoproliferation and its preparation |
| 09/22/2004 | CN1167428C External applied ointment for treating hyperosteogeny |
| 09/22/2004 | CN1167424C Notoginsenoside enteric tablet |
| 09/22/2004 | CN1167415C Orally applied solid preparation of medicine difficult to dissolve |
| 09/22/2004 | CN1167414C Preparation of pellet containing fat soluble substances |
| 09/22/2004 | CN1167413C Aerosol ointment compositions and preparation thereof |
| 09/22/2004 | CN1167412C Transdermal physiotherapeutic medicine gel |
| 09/21/2004 | US6794536 Method for preparation of disodium pamidronate |
| 09/21/2004 | US6794464 Membrane or matrix for controlling the permeation rate of drugs |
| 09/21/2004 | US6794416 Treatment of chronic obstructive pulmonary disease including chronic bronchitis, emphysema and asthma in humans that smoke or smoked cigarettes using aerosol or nebulizing device with or without concommitant treatment |
| 09/21/2004 | US6794411 Drinkable ibuprofen pharmaceutical suspension |
| 09/21/2004 | US6794391 Inhibitors of phosphodiesterase (pde) isoenzymes; useful for treatment of respiratory disorders such as asthma. |
| 09/21/2004 | US6794376 Delivering a therapeutic agent to said tissue; delivering a permeabilizer to the tissue; and elevating the temperature of the tissue to above normal body temperature. |
| 09/21/2004 | US6794367 Solid preparations for oral administration of drugs relating to genes |
| 09/21/2004 | US6794357 Compositions for inhalation |
| 09/21/2004 | US6793938 Sustained drug release |
| 09/21/2004 | US6793937 Entraining active material droplets in a hydrophilic matrix inside a hydrogel, suspending in a solution, applying to a substrate and allowing to dehydrate |
| 09/21/2004 | US6793936 Delivers an active ingredient in a pulsed or bimodal manner. |
| 09/21/2004 | US6793935 Improving swallowing through dispersing a large mass in a liquid and minimizing and eliminating gastric discomfort |
| 09/21/2004 | US6793934 Solid oral dosage form |
| 09/21/2004 | US6793933 Dietary supplements for enhancing the immune system |
| 09/21/2004 | US6793929 Preparations of the w/o emulsion type with an increased water content, comprising moderately polar lipids and silicone emulsifiers and, if desired, cationic polymers |
| 09/21/2004 | US6793923 Vaccines with enhanced immune response and methods for their preparation |
| 09/21/2004 | US6793912 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 09/21/2004 | US6793827 Method and device for preparing a medical fluid |
| 09/21/2004 | US6793675 Polysaccharide sponges for cell culture and transplantation |
| 09/21/2004 | CA2448468A1 Method and device for targeted epidermal delivery of medicinal and related agents |
| 09/21/2004 | CA2362857C Improved lactational performance of dairy cattle |
| 09/21/2004 | CA2284034C Comestible capsules having flavoured coatings |
| 09/21/2004 | CA2273272C Immediate release drug delivery forms |
| 09/21/2004 | CA2242986C Sustained release drug formulations |
| 09/21/2004 | CA2241502C A parenteral water-miscible non-intensely coloured injectable composition of non-steroidal anti-inflammatory drugs |
| 09/21/2004 | CA2192190C Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material |
| 09/21/2004 | CA2175225C Gelatin capsule fill able to foam |
| 09/21/2004 | CA2146757C Stabilization of fluorocarbon emulsions |
| 09/21/2004 | CA2094540C Orally-ingestible nutrition compositions having improved palatability |
| 09/18/2004 | CA2433205A1 Drug delivery, bodily fluid drainage, and biopsy device with enhanced ultrasonic visibility |
| 09/16/2004 | WO2004078791A1 Method to produce a solid form of heparin |
| 09/16/2004 | WO2004078677A2 Enhanced delivery of sphingolipids |
| 09/16/2004 | WO2004078250A2 Arrangement for remote-controlled release of active ingredients |
| 09/16/2004 | WO2004078214A1 Compositions for nasal absorption |
| 09/16/2004 | WO2004078212A1 Medicinal composition for regulating release and process for producing the same |
| 09/16/2004 | WO2004078211A1 Powdery preparation for nasal administration |
| 09/16/2004 | WO2004078198A1 Long acting injectable insulin composition and methods of making and using thereof |
| 09/16/2004 | WO2004078197A1 Delivery system for drug and cell therapy |
| 09/16/2004 | WO2004078196A1 Oral insulin composition and methods of making and using thereof |
| 09/16/2004 | WO2004078186A1 Ointment preparation for repairing injured skin |
| 09/16/2004 | WO2004078173A1 Tablet having improved dissolution characteristics |
| 09/16/2004 | WO2004078171A1 Tablet containing water-absorbing amino acid |
| 09/16/2004 | WO2004078165A1 Cataplasm base and cataplasm using the same |
| 09/16/2004 | WO2004078164A1 Control release formulation containing a hydrophobic material as the sustained release agent |
| 09/16/2004 | WO2004078163A2 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 09/16/2004 | WO2004078162A1 Nanoparticulate topiramate formulations |
| 09/16/2004 | WO2004078161A1 Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 09/16/2004 | WO2004078160A1 New process for the production of implants |
| 09/16/2004 | WO2004078149A1 Cosmetic and/or pharmaceutical preparations containing micro-encapsulated plant extracts |
| 09/16/2004 | WO2004078147A2 Oxytocin controlled release formulations and methods of using same |
| 09/16/2004 | WO2004078142A2 Compositions and methods for preventing and treating endotoxin-related diseases and conditions |
| 09/16/2004 | WO2004078139A2 Therapeutic compositions |
| 09/16/2004 | WO2004078122A2 Invisible patch for active agnet controlled delivery |
| 09/16/2004 | WO2004078121A2 Liposome composition for reduction of liposome-induced complement activation |
| 09/16/2004 | WO2004078111A2 Extended release minocycline compositions and processes for their preparation |
| 09/16/2004 | WO2004078108A2 Fibrate tablet and method for the production thereof |